Stock Market Stories and Insights
Will Cyclacel Pharmaceuticals (USA Stocks:CYCC) turn things around in April?
4 hours ago at Macroaxis By Nico Santiago |
- CYCC Cyclacel Pharmaceuticals
- Latest Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research Annual Meeting 2024
- CYCC 2.51 0.08
- Low 2.4
- High 2.59
- Volume 19.5 K
- Alpha -0.68
- Beta 1.5
- Return On Equity -1.87
- Return On Asset -0.83
- Operating Margin (427.81) %
- Current Valuation (2.69 M)
- Shares Outstanding 1.32 M
- Shares Owned By Insiders 5.92 %
- Shares Owned By Institutions 15.36 %
- Number Of Shares Shorted 41.48 K
- Price To Earning (0.40) X
- Price To Book 0.75 X
- Price To Sales 8.23 X
- Revenue 389 K
- Gross Profit (455 K)
- EBITDA (28.91 M)
- Net Income (24.7 M)
- Cash And Equivalents 29.08 M
- Cash Per Share 2.32 X
- Total Debt 106 K
- Debt To Equity 0 %
- Current Ratio 6.38 X
- Book Value Per Share 5.10 X
- Cash Flow From Operations (17.37 M)
- Short Ratio 0.67 X
- Earnings Per Share (29.85) X
- Target Price 93.0
- Beta 0.56
- Market Capitalization 3.2 M
- Total Asset 27.5 M
- Retained Earnings (406.16 M)
- Working Capital 17.02 M
- Current Asset 24.57 M
- Current Liabilities 5.75 M
- Z Score -5.26
- Net Asset 27.5 M
- Accumulation Distribution 1431.53
- Daily Balance Of Power 0.4211
- Rate Of Daily Change 1.03
- Day Median Price 2.5
- Day Typical Price 2.5
- Price Action Indicator 0.055
- Period Momentum Indicator 0.08
- Relative Strength Index 55.52
Reviewed by Raphi Shpitalnik
Main Ideas
Despite a slight dip in the day's open price at $13.51 and a minor price change of -$0.08, Escalade Incorporated (ESCA) presents a potentially smart investment opportunity with a potential upside of 3.94. The company's solid operating income of $17.7M and net income from continuing operations at $9.7M also contribute to its promising financial stability.21 hours ago at Macroaxis By Raphi Shpitalnik |
Main Points
Despite a loss in net income from continuing operations of 6.4M and a negative return on assets of 0.42, Vista Gold (VGZ) presents a potential investment opportunity due to its positive accumulation distribution of 0.11 and a recent price change increase of 0.05. With a book value of 0.041 and an open price of 0.48, the gold industry player is poised for a bullish turnaround in April, backed by its daily balance of power at 0.8333, indicating strong buying pressure.a day ago at Macroaxis By Rifka Kats |
a day ago at Macroaxis By Vlad Skutelnik |
The article provides an in-depth look at Fixed Assets Management Systems, tools designed to automate and streamline the management of an organization's fixed assets. These systems centralize data such as acquisition details, depreciation schedules, and maintenance records, offering benefits like enhanced efficiency, improved accuracy, cost control, and regulatory compliance.
2 days ago at Macroaxis By Aina Ster |
2 days ago at Macroaxis By Vlad Skutelnik |
2 days ago at Macroaxis By Gabriel Shpitalnik |
The article discusses the inherent risks in online lending, such as credit, fraud, operational, and market risks, and emphasizes the importance of recognizing these to develop effective management strategies. It highlights how technology revolutionizes risk management in this sector, utilizing advanced software, algorithms, and data analysis to quickly and accurately identify potential dangers. The guide explores how to foresee possible bumps in the road, make smart choices, and keep your online lending business safe and successful. We'll explore the tools and tactics that can help you not just survive but flourish in the digital finance landscape.
3 days ago at Macroaxis By Aina Ster |
Main Takeaways
Summit Midstream Partners operates within the Oil, Gas & Consumable Fuels sector, a part of the broader Energy industry.few days ago at Macroaxis By Gabriel Shpitalnik |